{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:50:43Z","timestamp":1791046243911,"version":"4.1.0"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T00:00:00Z","timestamp":1362441600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0058580","type":"journal-article","created":{"date-parts":[[2013,3,5]],"date-time":"2013-03-05T22:30:07Z","timestamp":1362522607000},"page":"e58580","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Transscleral Sustained Vasohibin-1 Delivery by a Novel Device Suppressed Experimentally-Induced Choroidal Neovascularization"],"prefix":"10.1371","volume":"8","author":[{"given":"Hideyuki","family":"Onami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matsuhiko","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasufumi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Osumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ajo.2003.11.069","article-title":"The epidemiology of age-related macular degeneration","volume":"137","author":"R Klein","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1001\/archopht.1986.01050170084028","article-title":"Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Macular Photocoagulation Study Group","volume":"104","journal-title":"Arch Ophthalmol"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Thomas MA, Grand MG, Williams DF, Lee CM, Pesin SR, <etal>et al<\/etal>.. (1992) Surgical management of subfoveal choroidal neovascularization. Ophthalmology 99: 952\u2013968; discussion 975\u2013956.","DOI":"10.1016\/S0161-6420(92)31888-3"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s004170050239","article-title":"Macular rotation with and without counter-rotation of the globe in patients with age-related macular degeneration","volume":"237","author":"C Eckardt","year":"1999","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1016\/S0161-6420(99)90400-1","article-title":"Transpupillary thermotherapy of occult subfoveal choroidal neovascularization in patients with age-related macular degeneration","volume":"106","author":"E Reichel","year":"1999","journal-title":"Ophthalmology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1001\/archopht.117.10.1329","article-title":"Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials \u2013 TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group","volume":"117","journal-title":"Arch Ophthalmol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.preteyeres.2008.05.002","article-title":"The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration","volume":"27","author":"S Grisanti","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"ref8","first-page":"574","article-title":"Vascular endothelial growth factor\/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model","volume":"145","author":"JW Miller","year":"1994","journal-title":"Am J Pathol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ajo.2007.12.036","article-title":"Endophthalmitis associated with intravitreal anti-vascular endothelial growth factor therapy injections in an office setting","volume":"145","author":"S Pilli","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1167\/iovs.05-0492","article-title":"Transscleral-RPE permeability of PEDF and ovalbumin proteins: implications for subconjunctival protein delivery","volume":"46","author":"J Amaral","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1167\/iovs.10-6291","article-title":"Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model","volume":"52","author":"TW Olsen","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant. A randomized controlled clinical trial","volume":"112","author":"DF Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0002-9394(01)01307-1","article-title":"Endophthalmitis associated with extrusion of a ganciclovir implant","volume":"133","author":"NC Charles","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3928\/1542-8877-20040501-16","article-title":"Post-surgical scleritis associated with the ganciclovir implant","volume":"35","author":"S Srivastava","year":"2004","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e19078","DOI":"10.1371\/journal.pone.0019078","article-title":"A non membrane-targeted human soluble CD59 attenuates choroidal neovascularization in a model of age related macular degeneration","volume":"6","author":"SM Cashman","year":"2011","journal-title":"PLoS One"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/hum.2006.17.167","article-title":"Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial","volume":"17","author":"PA Campochiaro","year":"2006","journal-title":"Hum Gene Ther"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"7927","DOI":"10.1200\/JCO.2004.00.1883","article-title":"Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir","volume":"23","author":"P Chevez-Barrios","year":"2005","journal-title":"J Clin Oncol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1517\/17425247.1.1.99","article-title":"Periocular routes for retinal drug delivery","volume":"1","author":"S Raghava","year":"2004","journal-title":"Expert Opin Drug Deliv"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00006982-200509000-00011","article-title":"Subconjunctival antibiotics in the treatment of endophthalmitis managed without vitrectomy","volume":"25","author":"WE Smiddy","year":"2005","journal-title":"Retina"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.preteyeres.2004.02.003","article-title":"Drug delivery systems for vitreoretinal diseases","volume":"23","author":"T Yasukawa","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jconrel.2010.08.028","article-title":"Barrier analysis of periocular drug delivery to the posterior segment","volume":"148","author":"VP Ranta","year":"2010","journal-title":"J Control Release"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0168-3659(00)00267-4","article-title":"Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis","volume":"68","author":"N Kunou","year":"2000","journal-title":"J Control Release"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2005.09.038","article-title":"The role of polymer membrane formation in sustained release drug delivery systems","volume":"109","author":"AJ McHugh","year":"2005","journal-title":"J Control Release"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.biomaterials.2010.11.006","article-title":"A scalable controlled-release device for transscleral drug delivery to the retina","volume":"32","author":"T Kawashima","year":"2011","journal-title":"Biomaterials"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1167\/iovs.10-6295","article-title":"Suppression of choroidal neovascularization by vasohibin-1, a vascular endothelium-derived angiogenic inhibitor","volume":"52","author":"R Wakusawa","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1172\/JCI200421152","article-title":"Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis","volume":"114","author":"K Watanabe","year":"2004","journal-title":"J Clin Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1096\/fj.05-5046fje","article-title":"Vasohibin is up-regulated by VEGF in the retina and suppresses VEGF receptor 2 and retinal neovascularization","volume":"20","author":"J Shen","year":"2006","journal-title":"FASEB J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/IAE.0b013e318233ad0b","article-title":"Reduction of laser-induced choroidal neovascularization by intravitreal vasohibin-1 in monkey eyes","volume":"32","author":"H Onami","year":"2012","journal-title":"Retina"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.2353\/ajpath.2010.090829","article-title":"Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis","volume":"176","author":"T Heishi","year":"2010","journal-title":"Am J Pathol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-4614-0631-0_40","article-title":"Vasohibin-1 and retinal pigment epithelium","volume":"723","author":"Y Ishikawa","year":"2012","journal-title":"Adv Exp Med Biol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/S0002-9440(10)65753-7","article-title":"Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model","volume":"153","author":"T Tobe","year":"1998","journal-title":"Am J Pathol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","article-title":"Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment","volume":"120","author":"MG Krzystolik","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1167\/iovs.07-1508","article-title":"Increased choroidal neovascularization following laser induction in mice lacking lysyl oxidase-like 1","volume":"49","author":"HG Yu","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1006\/exer.2000.0907","article-title":"Quantitative image analysis of laser-induced choroidal neovascularization in rat","volume":"71","author":"JL Edelman","year":"2000","journal-title":"Exp Eye Res"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ajo.2007.10.004","article-title":"Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1","volume":"145","author":"CD Regillo","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(01)05497-6","article-title":"Effect of infliximab on sight-threatening panuveitis in Behcet&apos;s disease","volume":"358","author":"PP Sfikakis","year":"2001","journal-title":"Lancet"},{"key":"ref37","first-page":"1362","article-title":"Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet&apos;s disease with refractory uveoretinitis","volume":"31","author":"S Ohno","year":"2004","journal-title":"J Rheumatol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jconrel.2009.10.031","article-title":"Nanoparticle-integrin antagonist C16Y peptide treatment of choroidal neovascularization in rats","volume":"142","author":"H Kim","year":"2010","journal-title":"J Control Release"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.exer.2005.08.007","article-title":"A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide","volume":"82","author":"MR Robinson","year":"2006","journal-title":"Exp Eye Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1167\/iovs.10-5337","article-title":"Evaluation of clearance mechanisms with transscleral drug delivery","volume":"51","author":"SJ Lee","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"4532","DOI":"10.1167\/iovs.06-0030","article-title":"Delivery from episcleral exoplants","volume":"47","author":"RA Pontes de Carvalho","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.preteyeres.2010.09.003","article-title":"Metabolic physiology in age related macular degeneration","volume":"30","author":"E Stefansson","year":"2011","journal-title":"Prog Retin Eye Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"e19911","DOI":"10.1371\/journal.pone.0019911","article-title":"Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction","volume":"6","author":"M Kondo","year":"2011","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJM198912073212307","article-title":"Cancer-associated retinopathy (CAR syndrome) with antibodies reacting with retinal, optic-nerve, and cancer cells","volume":"321","author":"CE Thirkill","year":"1989","journal-title":"N Engl J Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0039-6257(02)00416-2","article-title":"Paraneoplastic retinopathies and optic neuropathies","volume":"48","author":"JW Chan","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s11095-007-9408-z","article-title":"Drug elimination kinetics following subconjunctival injection using dynamic contrast-enhanced magnetic resonance imaging","volume":"25","author":"SH Kim","year":"2008","journal-title":"Pharm Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1600-0420.2007.01127.x","article-title":"Natural history of choroidal neovascularization after surgical induction in an animal model","volume":"86","author":"N Lassota","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Hayreh SS (2010) Submacular choroidal vascular bed watershed zones and their clinical importance. Am J Ophthalmol 150: 940\u2013941; author reply 941\u2013942.","DOI":"10.1016\/j.ajo.2010.08.011"},{"key":"ref49","first-page":"35","article-title":"Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration","volume":"5","author":"G Lutty","year":"1999","journal-title":"Mol Vis"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2009.08.003","article-title":"The dynamic nature of Bruch&apos;s membrane","volume":"29","author":"JC Booij","year":"2010","journal-title":"Prog Retin Eye Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0058580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T13:59:01Z","timestamp":1562767141000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0058580"}},"subtitle":[],"editor":[{"given":"Olaf","family":"Strau\u00df","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,3,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0058580","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}